What was it that catalyzed Yuka's traction? J.C.: The traction was almost instant. It was significantly due to word of mouth: ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...